E-LIB Suche - Ergebnisse für: Evans, Robert K.

1

Immune response and reactogenicity of an unadjuvanted intra..:

Meyer, Brian K. ; Kendall, Mark A.F. ; Williams, Donna M....
Vaccine: X. 2 (2019) - p. 100030 , 2019

Link: https://doi.org/10.1016/..

2

Safety Profile of the Merck Human Immunodeficiency Virus-1 ..:

Quirk, Erin K. ; Brown, Elizabeth L. ; Leavitt, Randi Y....
Open Forum Infectious Diseases. 1 (2014) 1 - p. , 2014

Link: https://doi.org/10.1093/..

3

The Use of Flow Cytometry for the Detection of Subvisible P..:

Mach, Henryk ; Bhambhani, Akhilesh ; Meyer, Brian K....
Journal of Pharmaceutical Sciences. 100 (2011) 5 - p. 1671-1678 , 2011

Link: https://doi.org/10.1002/..

4

Potent immunogenicity and efficacy of a universal influenza..:

Huleatt, James W. ; Nakaar, Valerian ; Desai, Priyanka...
Vaccine. 26 (2008) 2 - p. 201-214 , 2008

Link: https://doi.org/10.1016/..

5

Effect of pH and ionic strength on the physical stability o..:

Rexroad, Jason ; Evans, Robert K. ; Middaugh, C.Russell
Journal of Pharmaceutical Sciences. 95 (2006) 2 - p. 237-247 , 2006

Link: https://doi.org/10.1002/..

6

Molecular Mechanism and Thermodynamics Study of Plasmid DNA..:

Zhu, De-Min ; Evans, Robert K.
Langmuir. 22 (2006) 8 - p. 3735-3743 , 2006

Link: https://doi.org/10.1021/..

7

Production and Formulation of Adenovirus Vectors:

, In: Gene Therapy and Gene Delivery Systems; Advances in Biochemical Engineering/Biotechnology,

Altaras, Nedim E. ; Aunins, John G. ; Evans, Robert K.... - p. 193-260 , 2005

Link: https://doi.org/10.1007/..

8

Characterization and biological evaluation of a micropartic..:

Evans, Robert K. ; Zhu, De‐Min ; Casimiro, Danilo R....
Journal of Pharmaceutical Sciences. 93 (2004) 7 - p. 1924-1939 , 2004

Link: https://doi.org/10.1002/..

9

Development of stable liquid formulations for adenovirus-ba..:

Evans, Robert K. ; Nawrocki, Denise K. ; Isopi, Lynne A....
Journal of Pharmaceutical Sciences. 93 (2004) 10 - p. 2458-2475 , 2004

Link: https://doi.org/10.1002/..

10

Contributors:

, In: Office Practice of Neurology,

Adams, Robert J. ; Albers, James W. ; Alderson, Lloyd M.... - p. vii-xx , 2003

Link: https://doi.org/10.1016/..

11

Replication-incompetent adenoviral vaccine vector elicits e..:

Shiver, John W. ; Fu, Tong-Ming ; Chen, Ling...
Nature. 415 (2002) 6869 - p. 331-335 , 2002

Link: https://doi.org/10.1038/..

12

Evaluation of Degradation Pathways for Plasmid DNA in Pharm..:

Evans, Robert K. ; Xu, Zheng ; Bohannon, Kathryn E....
Journal of Pharmaceutical Sciences. 89 (2000) 1 - p. 76-87 , 2000

Link: https://doi.org/10.1002/..

13

Enhanced type I immune response to a hepatitis B DNA vaccin..:

Wang, Su ; Liu, Xu ; Fisher, Karen...
Vaccine. 18 (2000) 13 - p. 1227-1235 , 2000

Link: https://doi.org/10.1016/..

14

Analysis of Plasmid DNA from a Pharmaceutical Perspective:

Russell Middaugh, C. ; Evans, Robert K. ; Montgomery, Donna L..
Journal of Pharmaceutical Sciences. 87 (1998) 2 - p. 130-146 , 1998

Link: https://doi.org/10.1021/..

15

Purification and Characterization of the Vaccinia Virus Deo..:

Roseman, Nancy A. ; Evans, Robert K. ; Mayer, Erica L...
Journal of Biological Chemistry. 271 (1996) 38 - p. 23506-23511 , 1996

Link: https://doi.org/10.1074/..